Search

everythinglearnresearchcommunity

for

Search:↓

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

The patient responded well to treatment with no disease progression.

A young woman with lupus was treated with hydroxychloroquine and prednisone.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

Studying acne-related syndromes helps us understand acne causes and can lead to new treatments.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

RHUPUS should be considered in children with deforming arthritis.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

Cyclosporin doesn't stop hair loss.